A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy. Fan F, Liu P, Bao R, Chen J, et al. Cancer Res 2021;81:6233-6245.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fan F, Liu P, Bao R, Chen J, et al. A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy. Cancer Res 2021;81:6233-6245.
PMID: 34711611